|
Folinato 50mg
Folinic acid
- Strength / route
- 50mg · Injection
- Qty
- 3,000 Vial
- Total
- 229,950,000
- Group
- N1
- Manufacturer
- Laboratorios Normon, S.A. (Spain)
- Province / Facility
- Ho Chi Minh City · 79030
|
840110985224 |
50mg
Injection
|
Vial |
3,000
|
76,650
|
229,950,000
|
N1 |
Laboratorios Normon, S.A.
Spain
|
Ho Chi Minh City
79030
|
2026-03-12 |
|
Forlax
Macrogol (polyethylen glycol or polyoxyethylen glycol)
- Strength / route
- 10gam · Oral
- Qty
- 23,000 Sachet
- Total
- 117,737,000
- Group
- N1
- Manufacturer
- Beaufour Ipsen Industrie (France)
- Province / Facility
- Can Tho · 92086
|
VN-16801-13 |
10gam
Oral
|
Sachet |
23,000
|
5,119
|
117,737,000
|
N1 |
Beaufour Ipsen Industrie
France
|
Can Tho
92086
|
2026-03-12 |
|
Forlax
Macrogol
- Strength / route
- 10gam · Oral
- Qty
- 0 Sachet
- Total
- 0
- Group
- N1
- Manufacturer
- Beaufour Ipsen Industrie (France)
- Province / Facility
- Can Tho · 92151
|
VN-16801-13 |
10gam
Oral
|
Sachet |
0
|
5,119
|
0
|
N1 |
Beaufour Ipsen Industrie
France
|
Can Tho
92151
|
2026-03-12 |
|
Fortrans
Macrogol + natri sulfat + natri bicarbonat + natri clorid + kali clorid
- Strength / route
- 64g + 5,7g + 1,68g + 1,46g + 0,75g · Oral
- Qty
- 4,600 Sachet
- Total
- 165,462,000
- Group
- N1
- Manufacturer
- Beaufour Ipsen Industrie (France)
- Province / Facility
- Can Tho · 92086
|
VN-19677-16 |
64g + 5,7g + 1,68g + 1,46g + 0,75g
Oral
|
Sachet |
4,600
|
35,970
|
165,462,000
|
N1 |
Beaufour Ipsen Industrie
France
|
Can Tho
92086
|
2026-03-12 |
|
Fortrans
Macrogol + natri sulfat + natri bicarbonat + natri clorid + kali clorid
- Strength / route
- 64g + 5,7g + 1,68g + 1,46g + 0,75g · Oral
- Qty
- 0 Sachet
- Total
- 0
- Group
- N1
- Manufacturer
- Beaufour Ipsen Industrie (France)
- Province / Facility
- Can Tho · 92151
|
VN-19677-16 |
64g + 5,7g + 1,68g + 1,46g + 0,75g
Oral
|
Sachet |
0
|
35,970
|
0
|
N1 |
Beaufour Ipsen Industrie
France
|
Can Tho
92151
|
2026-03-12 |
|
Forxiga
Dapagliflozin
- Strength / route
- 10mg · Oral
- Qty
- 3,000 Tablet
- Total
- 57,000,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd (Manufacturing site: United States, Packaging and batch release site: United Kingdom)
- Province / Facility
- Hanoi · 01077
|
VN3-37-18 |
10mg
Oral
|
Tablet |
3,000
|
19,000
|
57,000,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd
Manufacturing site: United States, Packaging and batch release site: United Kingdom
|
Hanoi
01077
|
2026-03-12 |
|
Fucicort
Fusidic acid + betamethason
- Strength / route
- (2% (w/w) + 0,1% (w/w)) - 15g · Topical
- Qty
- 100 Tube
- Total
- 9,834,000
- Group
- N1
- Manufacturer
- LEO Laboratories Limited (Ireland)
- Province / Facility
- Phu Tho · 25359
|
539110417123 |
(2% (w/w) + 0,1% (w/w)) - 15g
Topical
|
Tube |
100
|
98,340
|
9,834,000
|
N1 |
LEO Laboratories Limited
Ireland
|
Phu Tho
25359
|
2026-03-12 |
|
Fucicort
Fusidic acid + betamethason
- Strength / route
- (2% (w/w) + 0,1% (w/w)) - 15g · Topical
- Qty
- 0 Tube
- Total
- 0
- Group
- N1
- Manufacturer
- LEO Laboratories Limited (Ireland)
- Province / Facility
- Phu Tho · 25359
|
VN-14208-11 |
(2% (w/w) + 0,1% (w/w)) - 15g
Topical
|
Tube |
0
|
98,340
|
0
|
N1 |
LEO Laboratories Limited
Ireland
|
Phu Tho
25359
|
2026-03-12 |
|
Fucidin
Fusidic acid
- Strength / route
- 2% (w/w); 15g · Topical
- Qty
- 600 Tube
- Total
- 45,045,000
- Group
- N1
- Manufacturer
- Leo Laboratories Limited (Ireland)
- Province / Facility
- Hanoi · 01043
|
VN-14209-11 |
2% (w/w); 15g
Topical
|
Tube |
600
|
75,075
|
45,045,000
|
N1 |
Leo Laboratories Limited
Ireland
|
Hanoi
01043
|
2026-03-12 |
|
Fulphila 6mg/0.6ml
Pegfilgrastim
- Strength / route
- 6mg · Injection
- Qty
- 2,300 Syringe
- Total
- 19,175,100,000
- Group
- N2
- Manufacturer
- Biocon Biologics Limited (India)
- Province / Facility
- Can Tho · 92086
|
890410303824 |
6mg
Injection
|
Syringe |
2,300
|
8,337,000
|
19,175,100,000
|
N2 |
Biocon Biologics Limited
India
|
Can Tho
92086
|
2026-03-12 |
|
Fulphila 6mg/0.6ml
Pegfilgrastim
- Strength / route
- 6mg · Injection
- Qty
- 0 Syringe
- Total
- 0
- Group
- N2
- Manufacturer
- Biocon Biologics Limited (India)
- Province / Facility
- Can Tho · 92151
|
890410303824 |
6mg
Injection
|
Syringe |
0
|
8,337,000
|
0
|
N2 |
Biocon Biologics Limited
India
|
Can Tho
92151
|
2026-03-12 |
|
Fulvestrant EVER Pharma 250 mg
Fulvestrant
- Strength / route
- 50mg/ml · Injection
- Qty
- 1,150 Syringe
- Total
- 2,829,000,000
- Group
- N1
- Manufacturer
- EVER Pharma Jena GmbH (Germany)
- Province / Facility
- Can Tho · 92086
|
400114972824 |
50mg/ml
Injection
|
Syringe |
1,150
|
2,460,000
|
2,829,000,000
|
N1 |
EVER Pharma Jena GmbH
Germany
|
Can Tho
92086
|
2026-03-12 |
|
Fulvestrant EVER Pharma 250 mg
Fulvestrant
- Strength / route
- 50mg/ml · Injection
- Qty
- 0 Syringe
- Total
- 0
- Group
- N1
- Manufacturer
- EVER Pharma Jena GmbH (Germany)
- Province / Facility
- Can Tho · 92151
|
400114972824 |
50mg/ml
Injection
|
Syringe |
0
|
2,460,000
|
0
|
N1 |
EVER Pharma Jena GmbH
Germany
|
Can Tho
92151
|
2026-03-12 |
|
Fungiact
Metronidazol + neomycin + nystatin
- Strength / route
- 500mg+ 65.000IU+ 100.000IU · Vaginal
- Qty
- 1,400 Tablet
- Total
- 10,850,000
- Group
- N2
- Manufacturer
- XL Laboratories Private Limited (India)
- Province / Facility
- Can Tho · 92086
|
890110046625 |
500mg+ 65.000IU+ 100.000IU
Vaginal
|
Tablet |
1,400
|
7,750
|
10,850,000
|
N2 |
XL Laboratories Private Limited
India
|
Can Tho
92086
|
2026-03-12 |
|
Fungiact
Metronidazol + neomycin + nystatin
- Strength / route
- 500mg+ 65.000IU+ 100.000IU · Vaginal
- Qty
- 0 Tablet
- Total
- 0
- Group
- N2
- Manufacturer
- XL Laboratories Private Limited (India)
- Province / Facility
- Can Tho · 92151
|
890110046625 |
500mg+ 65.000IU+ 100.000IU
Vaginal
|
Tablet |
0
|
7,750
|
0
|
N2 |
XL Laboratories Private Limited
India
|
Can Tho
92151
|
2026-03-12 |
|
Furlac 100
Furosemid
- Strength / route
- 10mg/ml;10ml · Injection
- Qty
- 400 Ampoule
- Total
- 11,440,000
- Group
- N4
- Manufacturer
- Medlac Pharma Italy Pharmaceutical Manufacturing Co., Ltd. (Vietnam)
- Province / Facility
- Can Tho · 92086
|
893110257324 |
10mg/ml;10ml
Injection
|
Ampoule |
400
|
28,600
|
11,440,000
|
N4 |
Medlac Pharma Italy Pharmaceutical Manufacturing Co., Ltd.
Vietnam
|
Can Tho
92086
|
2026-03-12 |
|
Furlac 100
Furosemid
- Strength / route
- 10mg/ml;10ml · Injection
- Qty
- 0 Ampoule
- Total
- 0
- Group
- N4
- Manufacturer
- Medlac Pharma Italy Pharmaceutical Manufacturing Co., Ltd. (Vietnam)
- Province / Facility
- Can Tho · 92151
|
893110257324 |
10mg/ml;10ml
Injection
|
Ampoule |
0
|
28,600
|
0
|
N4 |
Medlac Pharma Italy Pharmaceutical Manufacturing Co., Ltd.
Vietnam
|
Can Tho
92151
|
2026-03-12 |
|
GENSLER
Ramipril
- Strength / route
- 5mg · Oral
- Qty
- 304,080 Tablet
- Total
- 789,087,600
- Group
- N2
- Manufacturer
- Dat Vi Phu Pharmaceutical JSC (Vietnam)
- Province / Facility
- Ho Chi Minh City
|
893110152224 |
5mg
Oral
|
Tablet |
304,080
|
2,595
|
789,087,600
|
N2 |
Dat Vi Phu Pharmaceutical JSC
Vietnam
|
Ho Chi Minh City
|
2026-03-12 |
|
GLARITUS
Insulin glargine
- Strength / route
- 100IU/1ml · Injection
- Qty
- 9,200 Pen injector
- Total
- 1,978,000,000
- Group
- N5
- Manufacturer
- Wockhardt Limited (India)
- Province / Facility
- Can Tho · 92086
|
890410091623 |
100IU/1ml
Injection
|
Pen injector |
9,200
|
215,000
|
1,978,000,000
|
N5 |
Wockhardt Limited
India
|
Can Tho
92086
|
2026-03-12 |
|
GLARITUS
Insulin glargine
- Strength / route
- 100IU/1ml · Injection
- Qty
- 0 Pen injector
- Total
- 0
- Group
- N5
- Manufacturer
- Wockhardt Limited (India)
- Province / Facility
- Can Tho · 92151
|
890410091623 |
100IU/1ml
Injection
|
Pen injector |
0
|
215,000
|
0
|
N5 |
Wockhardt Limited
India
|
Can Tho
92151
|
2026-03-12 |
|
GONCAL
Calci carbonat+ calci gluconolactat
- Strength / route
- 150mg+1470mg · Oral
- Qty
- 23,000 Tablet
- Total
- 44,850,000
- Group
- N2
- Manufacturer
- Dat Vi Phu Pharmaceutical JSC (Vietnam)
- Province / Facility
- Can Tho · 92086
|
VD-20946-14 |
150mg+1470mg
Oral
|
Tablet |
23,000
|
1,950
|
44,850,000
|
N2 |
Dat Vi Phu Pharmaceutical JSC
Vietnam
|
Can Tho
92086
|
2026-03-12 |
|
GONCAL
Calci carbonat+ calci gluconolactat
- Strength / route
- 150mg+1470mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N2
- Manufacturer
- Dat Vi Phu Pharmaceutical JSC (Vietnam)
- Province / Facility
- Can Tho · 92151
|
VD-20946-14 |
150mg+1470mg
Oral
|
Tablet |
0
|
1,950
|
0
|
N2 |
Dat Vi Phu Pharmaceutical JSC
Vietnam
|
Can Tho
92151
|
2026-03-12 |
|
Gabatin
Gabapentin
- Strength / route
- 400mg/8ml; 8ml · Oral
- Qty
- 50,000 Ampoule
- Total
- 325,000,000
- Group
- N4
- Manufacturer
- Apimed Pharmaceutical JSC (Vietnam)
- Province / Facility
- Long An
|
893110200225 |
400mg/8ml; 8ml
Oral
|
Ampoule |
50,000
|
6,500
|
325,000,000
|
N4 |
Apimed Pharmaceutical JSC
Vietnam
|
Long An
|
2026-03-12 |
|
Gaptinew
Gabapentin
- Strength / route
- 300mg · Oral
- Qty
- 34,500 Tablet
- Total
- 12,075,000
- Group
- N4
- Manufacturer
- Agimexpharm Pharmaceutical JSC – Binh Hoa Branch (Vietnam)
- Province / Facility
- Can Tho · 92086
|
893110258223 |
300mg
Oral
|
Tablet |
34,500
|
350
|
12,075,000
|
N4 |
Agimexpharm Pharmaceutical JSC – Binh Hoa Branch
Vietnam
|
Can Tho
92086
|
2026-03-12 |
|
Gaptinew
Gabapentin
- Strength / route
- 300mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N4
- Manufacturer
- Agimexpharm Pharmaceutical JSC – Binh Hoa Branch (Vietnam)
- Province / Facility
- Can Tho · 92151
|
893110258223 |
300mg
Oral
|
Tablet |
0
|
350
|
0
|
N4 |
Agimexpharm Pharmaceutical JSC – Binh Hoa Branch
Vietnam
|
Can Tho
92151
|
2026-03-12 |
|
Gefitinib Sandoz
Gefitinib
- Strength / route
- 250mg · Oral
- Qty
- 6,900 Tablet
- Total
- 1,062,600,000
- Group
- N1
- Manufacturer
- Manufacturing and packaging site: Remedica Ltd/ Site responsible for batch release: Lek Pharmaceuticals D.D (Cyprus)
- Province / Facility
- Can Tho · 92086
|
529114776224 |
250mg
Oral
|
Tablet |
6,900
|
154,000
|
1,062,600,000
|
N1 |
Manufacturing and packaging site: Remedica Ltd/ Site responsible for batch release: Lek Pharmaceuticals D.D
Cyprus
|
Can Tho
92086
|
2026-03-12 |
|
Gefitinib Sandoz
Gefitinib
- Strength / route
- 250mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Manufacturing and packaging site: Remedica Ltd/ Site responsible for batch release: Lek Pharmaceuticals D.D (Cyprus)
- Province / Facility
- Can Tho · 92151
|
529114776224 |
250mg
Oral
|
Tablet |
0
|
154,000
|
0
|
N1 |
Manufacturing and packaging site: Remedica Ltd/ Site responsible for batch release: Lek Pharmaceuticals D.D
Cyprus
|
Can Tho
92151
|
2026-03-12 |
|
Gel-Aphos
Aluminum phosphat
- Strength / route
- 20% , 12,38g · Oral
- Qty
- 23,000 Sachet
- Total
- 27,830,000
- Group
- N4
- Manufacturer
- Agimexpharm Pharmaceutical JSC – Branch – Agimexpharm Pharmaceutical Manufacturing Factory (Vietnam)
- Province / Facility
- Can Tho · 92086
|
893110144824 |
20% , 12,38g
Oral
|
Sachet |
23,000
|
1,210
|
27,830,000
|
N4 |
Agimexpharm Pharmaceutical JSC – Branch – Agimexpharm Pharmaceutical Manufacturing Factory
Vietnam
|
Can Tho
92086
|
2026-03-12 |
|
Gel-Aphos
Aluminum phosphat
- Strength / route
- 20% , 12,38g · Oral
- Qty
- 0 Sachet
- Total
- 0
- Group
- N4
- Manufacturer
- Agimexpharm Pharmaceutical JSC – Branch – Agimexpharm Pharmaceutical Manufacturing Factory (Vietnam)
- Province / Facility
- Can Tho · 92151
|
893110144824 |
20% , 12,38g
Oral
|
Sachet |
0
|
1,210
|
0
|
N4 |
Agimexpharm Pharmaceutical JSC – Branch – Agimexpharm Pharmaceutical Manufacturing Factory
Vietnam
|
Can Tho
92151
|
2026-03-12 |
|
Gelofusine
Gelatin succinyl + natri clorid +natri hydroxyd
- Strength / route
- (20g+3,505g+0,68g)/500ml · Infusion
- Qty
- 690 Chai
- Total
- 80,040,000
- Group
- N5
- Manufacturer
- B.Braun Medical Industries Sdn. Bhd. (Malaysia)
- Province / Facility
- Can Tho · 92086
|
955110002024 |
(20g+3,505g+0,68g)/500ml
Infusion
|
Chai |
690
|
116,000
|
80,040,000
|
N5 |
B.Braun Medical Industries Sdn. Bhd.
Malaysia
|
Can Tho
92086
|
2026-03-12 |
|
Gelofusine
Gelatin succinyl + natri clorid +natri hydroxyd
- Strength / route
- (20g+3,505g+0,68g)/500ml · Infusion
- Qty
- 0 Chai
- Total
- 0
- Group
- N5
- Manufacturer
- B.Braun Medical Industries Sdn. Bhd. (Malaysia)
- Province / Facility
- Can Tho · 92151
|
955110002024 |
(20g+3,505g+0,68g)/500ml
Infusion
|
Chai |
0
|
116,000
|
0
|
N5 |
B.Braun Medical Industries Sdn. Bhd.
Malaysia
|
Can Tho
92151
|
2026-03-12 |
|
Geloplasma
Gelatin
- Strength / route
- each tui 500ml contains: Gelatin anhydrous (as gelatin long bien tinh) 15g; sodium chloride 2.691g; magnesium chloride hexahydrat 0.1525g; potassium chloride 0.1865g; sodium lactate (as dung dich sodium (S)-lactat · Infusion
- Qty
- 20 Bag
- Total
- 2,200,000
- Group
- N1
- Manufacturer
- Fresenius Kabi France (France)
- Province / Facility
- Tien Giang · 82011
|
VN-19838-16 |
each tui 500ml contains: Gelatin anhydrous (as gelatin long bien tinh) 15g; sodium chloride 2.691g; magnesium chloride hexahydrat 0.1525g; potassium chloride 0.1865g; sodium lactate (as dung dich sodium (S)-lactat
Infusion
|
Bag |
20
|
110,000
|
2,200,000
|
N1 |
Fresenius Kabi France
France
|
Tien Giang
82011
|
2026-03-12 |
|
Gemapaxane
Enoxaparin Natri
- Strength / route
- 4000IU/0,4ml · Injection
- Qty
- 5,750 Syringe
- Total
- 402,500,000
- Group
- N1
- Manufacturer
- Italfarmaco S.p.A (Italy)
- Province / Facility
- Can Tho · 92086
|
800410092123 |
4000IU/0,4ml
Injection
|
Syringe |
5,750
|
70,000
|
402,500,000
|
N1 |
Italfarmaco S.p.A
Italy
|
Can Tho
92086
|
2026-03-12 |
|
Gemapaxane
Enoxaparin Natri
- Strength / route
- 4000IU/0,4ml · Injection
- Qty
- 0 Syringe
- Total
- 0
- Group
- N1
- Manufacturer
- Italfarmaco S.p.A (Italy)
- Province / Facility
- Can Tho · 92151
|
800410092123 |
4000IU/0,4ml
Injection
|
Syringe |
0
|
70,000
|
0
|
N1 |
Italfarmaco S.p.A
Italy
|
Can Tho
92151
|
2026-03-12 |
|
Gemcitabine For Injection 1000mg/Vial
Gemcitabin
- Strength / route
- 1000mg · Intravenous
- Qty
- 6,900 Vial
- Total
- 1,896,810,000
- Group
- N2
- Manufacturer
- Hetero Labs Limited (India)
- Province / Facility
- Can Tho · 92086
|
890114974524 |
1000mg
Intravenous
|
Vial |
6,900
|
274,900
|
1,896,810,000
|
N2 |
Hetero Labs Limited
India
|
Can Tho
92086
|
2026-03-12 |
|
Gemcitabine For Injection 1000mg/Vial
Gemcitabin
- Strength / route
- 1000mg · Intravenous
- Qty
- 0 Vial
- Total
- 0
- Group
- N2
- Manufacturer
- Hetero Labs Limited (India)
- Province / Facility
- Can Tho · 92151
|
890114974524 |
1000mg
Intravenous
|
Vial |
0
|
274,900
|
0
|
N2 |
Hetero Labs Limited
India
|
Can Tho
92151
|
2026-03-12 |
|
Gemita 200mg
Gemcitabin
- Strength / route
- 200mg · Intravenous infusion
- Qty
- 2,300 Vial
- Total
- 264,500,000
- Group
- N2
- Manufacturer
- Fresenius Kabi Oncology Limited (India)
- Province / Facility
- Can Tho · 92086
|
VN-21730-19 |
200mg
Intravenous infusion
|
Vial |
2,300
|
115,000
|
264,500,000
|
N2 |
Fresenius Kabi Oncology Limited
India
|
Can Tho
92086
|
2026-03-12 |
|
Gemita 200mg
Gemcitabin
- Strength / route
- 200mg · Intravenous infusion
- Qty
- 0 Vial
- Total
- 0
- Group
- N2
- Manufacturer
- Fresenius Kabi Oncology Limited (India)
- Province / Facility
- Can Tho · 92151
|
VN-21730-19 |
200mg
Intravenous infusion
|
Vial |
0
|
115,000
|
0
|
N2 |
Fresenius Kabi Oncology Limited
India
|
Can Tho
92151
|
2026-03-12 |
|
Gemzar
Gemcitabin
- Strength / route
- 200mg · Infusion
- Qty
- 70 Vial
- Total
- 51,485,000
- Group
- N1
- Manufacturer
- Manufacturing and primary packaging site: Vianex S.A-Plant C; Secondary packaging and batch release site: Lilly France (Manufacturing and primary packaging site: Greece; Secondary packaging and batch release site: France)
- Province / Facility
- Hanoi · 01043
|
520114446123 |
200mg
Infusion
|
Vial |
70
|
735,500
|
51,485,000
|
N1 |
Manufacturing and primary packaging site: Vianex S.A-Plant C; Secondary packaging and batch release site: Lilly France
Manufacturing and primary packaging site: Greece; Secondary packaging and batch release site: France
|
Hanoi
01043
|
2026-03-12 |
|
Gemzar
Gemcitabin
- Strength / route
- 1000mg · Infusion
- Qty
- 30 Vial
- Total
- 81,792,000
- Group
- N1
- Manufacturer
- Manufacturing and primary packaging site: Vianex S.A-Plant C; Secondary packaging and batch release site: Lilly France (Manufacturing and primary packaging site: Greece; Secondary packaging and batch release site: France)
- Province / Facility
- Hanoi · 01043
|
520114195923 |
1000mg
Infusion
|
Vial |
30
|
2,726,400
|
81,792,000
|
N1 |
Manufacturing and primary packaging site: Vianex S.A-Plant C; Secondary packaging and batch release site: Lilly France
Manufacturing and primary packaging site: Greece; Secondary packaging and batch release site: France
|
Hanoi
01043
|
2026-03-12 |
|
Geumi
Salbutamol sulfat
- Strength / route
- 5mg/5ml · Injection
- Qty
- 4,000 Ampoule
- Total
- 420,000,000
- Group
- N4
- Manufacturer
- CPC1 Hanoi Pharmaceutical JSC (Vietnam)
- Province / Facility
- Cao Bang · 04014
|
893115281423 |
5mg/5ml
Injection
|
Ampoule |
4,000
|
105,000
|
420,000,000
|
N4 |
CPC1 Hanoi Pharmaceutical JSC
Vietnam
|
Cao Bang
04014
|
2026-03-12 |
|
Giotrif
Afatinib dimaleate
- Strength / route
- 40mg · Oral
- Qty
- 840 Tablet
- Total
- 649,063,800
- Group
- N1
- Manufacturer
- Boehringer Ingelheim Pharma GmbH & Co. KG (Germany)
- Province / Facility
- Hanoi · 01043
|
VN2-603-17 |
40mg
Oral
|
Tablet |
840
|
772,695
|
649,063,800
|
N1 |
Boehringer Ingelheim Pharma GmbH & Co. KG
Germany
|
Hanoi
01043
|
2026-03-12 |
|
Giotrif
Afatinib dimaleate
- Strength / route
- 30mg · Oral
- Qty
- 1,120 Tablet
- Total
- 865,418,400
- Group
- N1
- Manufacturer
- Boehringer Ingelheim Pharma GmbH & Co. KG (Germany)
- Province / Facility
- Hanoi · 01043
|
VN2-602-17 |
30mg
Oral
|
Tablet |
1,120
|
772,695
|
865,418,400
|
N1 |
Boehringer Ingelheim Pharma GmbH & Co. KG
Germany
|
Hanoi
01043
|
2026-03-12 |
|
Giotrif
Afatinib dimaleate
- Strength / route
- 20mg · Oral
- Qty
- 280 Tablet
- Total
- 216,354,600
- Group
- N1
- Manufacturer
- Boehringer Ingelheim Pharma GmbH & Co. KG (Germany)
- Province / Facility
- Hanoi · 01043
|
400110034923 |
20mg
Oral
|
Tablet |
280
|
772,695
|
216,354,600
|
N1 |
Boehringer Ingelheim Pharma GmbH & Co. KG
Germany
|
Hanoi
01043
|
2026-03-12 |
|
Gliclazide Tablets BP 80mg
Gliclazid
- Strength / route
- 80mg · Oral
- Qty
- 2,000 Tablet
- Total
- 3,780,000
- Group
- N3
- Manufacturer
- Flamingo Pharmaceuticals Ltd (India)
- Province / Facility
- Cao Bang · 04090
|
890110352524 |
80mg
Oral
|
Tablet |
2,000
|
1,890
|
3,780,000
|
N3 |
Flamingo Pharmaceuticals Ltd
India
|
Cao Bang
04090
|
2026-03-12 |
|
Gliclazide Tablets BP 80mg
Gliclazid
- Strength / route
- 80mg · Oral
- Qty
- 10,000 Tablet
- Total
- 18,900,000
- Group
- N3
- Manufacturer
- Flamingo Pharmaceuticals Ltd (India)
- Province / Facility
- Cao Bang · 04005
|
890110352524 |
80mg
Oral
|
Tablet |
10,000
|
1,890
|
18,900,000
|
N3 |
Flamingo Pharmaceuticals Ltd
India
|
Cao Bang
04005
|
2026-03-12 |
|
Gliclazide Tablets BP 80mg
Gliclazid
- Strength / route
- 80mg · Oral
- Qty
- 3,000 Tablet
- Total
- 5,670,000
- Group
- N3
- Manufacturer
- Flamingo Pharmaceuticals Ltd (India)
- Province / Facility
- Cao Bang · 04110
|
890110352524 |
80mg
Oral
|
Tablet |
3,000
|
1,890
|
5,670,000
|
N3 |
Flamingo Pharmaceuticals Ltd
India
|
Cao Bang
04110
|
2026-03-12 |
|
Gliclazide Tablets BP 80mg
Gliclazid
- Strength / route
- 80mg · Oral
- Qty
- 1,000 Tablet
- Total
- 1,890,000
- Group
- N3
- Manufacturer
- Flamingo Pharmaceuticals Ltd (India)
- Province / Facility
- Cao Bang · 04086
|
890110352524 |
80mg
Oral
|
Tablet |
1,000
|
1,890
|
1,890,000
|
N3 |
Flamingo Pharmaceuticals Ltd
India
|
Cao Bang
04086
|
2026-03-12 |
|
Gliclazide Tablets BP 80mg
Gliclazid
- Strength / route
- 80mg · Oral
- Qty
- 10,000 Tablet
- Total
- 18,900,000
- Group
- N3
- Manufacturer
- Flamingo Pharmaceuticals Ltd (India)
- Province / Facility
- Cao Bang · 04089
|
890110352524 |
80mg
Oral
|
Tablet |
10,000
|
1,890
|
18,900,000
|
N3 |
Flamingo Pharmaceuticals Ltd
India
|
Cao Bang
04089
|
2026-03-12 |
|
Gliclazide Tablets BP 80mg
Gliclazid
- Strength / route
- 80mg · Oral
- Qty
- 5,000 Tablet
- Total
- 9,450,000
- Group
- N3
- Manufacturer
- Flamingo Pharmaceuticals Ltd (India)
- Province / Facility
- Cao Bang · 04084
|
890110352524 |
80mg
Oral
|
Tablet |
5,000
|
1,890
|
9,450,000
|
N3 |
Flamingo Pharmaceuticals Ltd
India
|
Cao Bang
04084
|
2026-03-12 |
